Legend Biotechcorp Stock Fundamentals
| LEGN Stock | USD 51.71 1.21 2.29% |
Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.
At this time, Legend BiotechCorp's Interest Expense is very stable compared to the past year. As of the 16th of April 2024, Selling General Administrative is likely to grow to about 112.1 M, while Tax Provision is likely to drop about 268.9 K. Legend | Select Account or Indicator |
Legend BiotechCorp Company Return On Asset Analysis
Legend BiotechCorp's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Legend BiotechCorp Return On Asset | -0.17 |
Most of Legend BiotechCorp's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Legend Total Assets
Total Assets |
|
Based on the latest financial disclosure, Legend BiotechCorp has a Return On Asset of -0.1739. This is 98.01% lower than that of the Biotechnology sector and 99.26% lower than that of the Health Care industry. The return on asset for all United States stocks is 24.21% higher than that of the company.
Legend BiotechCorp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Legend BiotechCorp's current stock value. Our valuation model uses many indicators to compare Legend BiotechCorp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Legend BiotechCorp competition to find correlations between indicators driving Legend BiotechCorp's intrinsic value. More Info.Legend BiotechCorp is rated second overall in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies . At this time, Legend BiotechCorp's Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Legend BiotechCorp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Legend BiotechCorp's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Legend BiotechCorp's earnings, one of the primary drivers of an investment's value.Legend Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.Legend BiotechCorp is currently under evaluation in return on asset category among related companies.
Legend Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (1.82) % | ||||
| Operating Margin | (1.52) % | ||||
| Current Valuation | 18.27 B | ||||
| Shares Outstanding | 181.91 M | ||||
| Shares Owned By Insiders | 1.30 % | ||||
| Shares Owned By Institutions | 48.71 % | ||||
| Number Of Shares Shorted | 9.99 M | ||||
| Price To Book | 7.69 X | ||||
| Price To Sales | 33.76 X | ||||
| Revenue | 285.14 M | ||||
| Gross Profit | (284.01 M) | ||||
| EBITDA | (421.76 M) | ||||
| Net Income | (518.25 M) | ||||
| Cash And Equivalents | 791.26 M | ||||
| Cash Per Share | 5.11 X | ||||
| Total Debt | 328.67 M | ||||
| Debt To Equity | 0.29 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 6.88 X | ||||
| Cash Flow From Operations | (384.47 M) | ||||
| Short Ratio | 9.56 X | ||||
| Earnings Per Share | (2.94) X | ||||
| Target Price | 86.16 | ||||
| Number Of Employees | 1.8 K | ||||
| Beta | 0.014 | ||||
| Market Capitalization | 9.63 B | ||||
| Total Asset | 1.85 B | ||||
| Retained Earnings | (1.48 B) | ||||
| Working Capital | 1.28 B | ||||
| Net Asset | 1.85 B |
About Legend BiotechCorp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 53 M | 34.2 M | |
| Total Revenue | 285.1 M | 299.4 M | |
| Cost Of Revenue | 164.7 M | 155.1 M | |
| Stock Based Compensation To Revenue | 0.17 | 0.10 | |
| Sales General And Administrative To Revenue | 0.37 | 0.27 | |
| Research And Ddevelopement To Revenue | 1.34 | 1.98 | |
| Capex To Revenue | (0.43) | (0.45) | |
| Revenue Per Share | 1.62 | 1.70 | |
| Ebit Per Revenue | (1.55) | (1.63) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.